A Study on the Preference of Risperidone Dosage Forms

Shanghai Mental Health Center

Status: Enrolling

Conditions: Autism Spectrum Disorder; Schizophrenia; Conduct Disorder; Bipolar Affective Disorder; Mental Retardation

Study type: Observational

Funder types: Other

Identifiers

NCT06657430

2024-85

Details and patient eligibility

About

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Full description

This study aims to understand patients' needs and preferences for antipsychotic dosage forms and to clarify the clinical value of patch-form antipsychotics.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

Exclusion criteria

• Have difficulty reading and understanding Chinese or refuse to participate in the study.

Trial design

1,000 participants in 1 patient group

Patients and their caregivers

Description:

Patients (and their caregivers) with psychiatric disorders for which risperidone is indicated, including schizophrenia, bipolar disorder, autism spectrum disorder, conduct disorder, and mental retardation.